Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS

Kidney International

Volumn 65, Issue 6, 2004, Pages 2335-2342

  Fissell, Rachel B ^a   Bragg Gresham, Jennifer L ^b   Woods, John D ^b   Jadoul, Michel ^b   Gillespie, Brenda ^b   Hedderwick, Sara A ^b   Rayner, Hugh C ^b   Greenwood, Roger N ^b   Akiba, Takashi ^b   Young, Eric W ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE

Author keywords

Dialysis Outcomes and Practice Patterns Study; Hepatitis c; Infection control protocols; Seroconversion

Indexed keywords

ALCOHOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL ABUSE; ARTICLE; CELLULITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS; FEMALE; FRANCE; GANGRENE; GENDER; GERMANY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEMODIALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; ITALY; JAPAN; KIDNEY GRAFT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MULTICENTER STUDY; NONHUMAN; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RANDOMIZED CONTROLLED TRIAL; RECURRENT ABORTION; RISK ASSESSMENT; SAMPLING; SEROCONVERSION; SPAIN; STAFF; SUBSTANCE ABUSE; TRAINING; UNITED KINGDOM; UNITED STATES; VIRUS ISOLATION;

EID: 2442642562     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00649.x     Document Type: Article

References (38)

1. CENTERS FOR DISEASE CONTROL AND PREVENTION: Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Morb Mortal Wkly Rep 50(RR-5):1-43, 2001
2. DEMEDINA M, ASHBY M, SCHLUTER V, et al: Prevalence of hepatitis C and G virus infection in chronic hemodialysis patients. Am J Kidney Dis 31:224-226, 1998
3. ALMROTH G, EKERMO B, MANSSON AS, et al: Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long-term follow up (1989-January 1997). J Int Med 251:119-128, 2002
4. BUKH J, WANTZIN P, KROGSGAARD K, et al, and THE COPENHAGEN DIALYSIS HCV STUDY GROUP: High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: Failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 168:1343-1348, 1993
5. FABRIZI F, POORDAD FF, MARTIN P: Hepatitis C infection and the patient with end-stage renal disease. Hepatology 36:3-10, 2002
6. LAUER GM, WALKER BD: Hepatitis C virus infection. N Engl J Med 345:41-52, 2001
7. BASSIT L, VAN HEUVERSWYN H, DE BOSSCHERE K, et al: Comparative study of two anti-HCV screening tests in a large genotyped population of Brazilian dialysis patients. Eur J Clin Microbiol Infect Dis 21:404-406, 2002
8. FABRIZI F, LUNGHI G, GUARNORI I, et al: Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: A cross-sectional study. Clin Nephrol 44:49-55, 1995
9. NAKAYAMA E, AKIBA T, MARUMO F, SATO C: Prognosis of antihepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 11:1896-1902, 2000
10. MAISONNEUVE P, AGODOA L, GELLERT R, et al: Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 354:93-99, 1999
11. HANAFUSA T, ICHIKAWA Y, KISHIKAWA H, et al: Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 66:471-476, 1998
12. MATHURIN P, MOUQUET C, POYNARD T, et al: Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 29:257-263, 1999
13. RAO KV, MA J: Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 62:1765-1769, 1996
14. HINRICHSEN H, LEIMENSTOLL G, STEGEN G, et al: Prevalence of and risk factors for hepatitis C virus infection in haemodialysis patients: A multicentre study in 2796 patients. Gut 51:429-433, 2002
15. HANUKA N, SIKULER E, TOVBIN D, et al: Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies. J Viral Hepat 9:141-145, 2002
16. JADOUL M, CORNU C, VAN YPERSELE DE STRIHOU C, AND THE UCL COLLABORATIVE GROUP: Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 44: 1322-1326, 1993
17. YOUNG EW, GOODKIN DA, MAPES DL, et al: The Dialysis Outcomes and Practice Patterns Study: An international hemodialysis study. Kidney Int 57(Suppl 74):S74-S81, 2000
18. SAS/STAT User's Guide, version 8, Cary, NC, SAS Institute, Cary, NC, volume 2, page 1452
19. KLEIN J, MOESCHBERGER M: Survival Analysis Techniques for Censored and Truncated Data, New York, Springer, 1997, pp 416-418
20. TOKARS JI, FRANK M, ALTER MJ, et al: National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 15:162-171, 2002
21. PETROSILLO N, GILLI P, SERRAINO D, et al: Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 37:1004-1010, 2001
22. SALAMA G, ROSTAING L, SANDRES K, et al: Hepatitis C virus infection in French hemodialysis units: A multicenter study. J Med Virol 61:44-51, 2000
23. NAKAI S, SHINZATO T, SANAKA T, et al: An overview of dialysis treatment in Japan. J Jpn Soc Dial Ther 34:1121-1147, 2001
24. CHAUVEAU PH: Epidemiology of hepatitis C virus infection in chronic hemodialysis. Nephrol Dial Transplant 11 (Suppl 4):39-41, 1996
25. FABRIZI F, LUNGHI G, MARTIN P: Treatment of HCV-related liver disease in the dialysis population: A novel challenge for clinical nephrologists. Int J Artif Organs 24:335-346, 2001
26. MORIYA T, KOYAMA T, TANAKA J, et al: Epidemiology of hepatitis C virus in Japan. Intervirology 42:153-158, 1999
27. WASLEY A, ALTER MJ: Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin Liver Dis 20:1-16, 2000
28. LOMBARDI M, CERRAI T, GEATTI S, et al: Results of a national epidemiological investigation on HCV infection among dialysis patients (Survey by the Italian Branch of EDTNA/ERCA). J Nephrol 12:322-327, 1999
29. MORALES JM: Hepatitis C and renal transplantation: Outcome of patients. Nephrol Dial Transplant 10:125-128, 1995
30. HARDY NM, SANDRONI S, DANIELSON S, et al: Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 38:44-48, 1992
31. SCHROTER M, FEUGHT HH, SCHAFER P, et al: High percentage of seronegative HCV infections in hemodialysis patients: The need for PCR. Intervirology 40:277-278, 1997
32. SEELIG R, RENZ M, BOTTNER C, et al: Hepatitis C virus infections in dialysis units: Prevalence of RNA and antibodies to HCV. Ann Med 26:45-52, 1994
33. GILLI P, SOFFRITTI S, DE PAOLI VITALI E, BEDANI PL: Prevention of hepatitis C in dialysis units. Nephron 70:301-306, 1995
34. JADOUL M, CORNU C, VAN YPERSELE DE STRIHOU C, AND THE UCL COLLABORATIVE GROUP: Universal precautions prevent hepatitis C virus transmission: A 54-month follow-up of the Belgian multicenter study. Kidney Int 53:1022-1025, 1998
35. MOYER LA, ALTER MJ: Hepatitis C virus in the hemodialysis setting: A review with recommendations for control. Semin Dial 7:124-127, 1994
36. DJORDJEVIC V, STOJANOVIC K, STOJANOVIC M, STEFANOVIC V: Prevalence of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study. Int J Artif Organs 23:181-188, 2000
37. TASKAPAN H, OYMAK O, DOGUKAN A, et al: Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin Nephrol 55:477-481, 2001
38. NEEDLEMAN J, BUERHAUS P, MATTKE S, et al: Nurse-staffing levels and the quality of care in hospitals. N Engl J Med 346:1715-1722, 2002